Related references
Note: Only part of the references are listed.Opioid Abuse: A Detailed Examination of Cost Drivers over a 24-Month Follow-up Period
Lauren M. Scarpati et al.
Journal of Managed Care & Specialty Pharmacy (2017)
Meeting Abstracts - Academy of Managed Care Pharmacy Nexus 2017
Journal of Managed Care & Specialty Pharmacy (2017)
Costs and Work Loss Burden of Diagnosed Opioid Abuse Among Employees on Workers Compensation or Short-term Disability
Stephen S. Johnston et al.
JOURNAL OF OCCUPATIONAL AND ENVIRONMENTAL MEDICINE (2016)
The Economic Burden of Prescription Opioid Overdose, Abuse, and Dependence in the United States, 2013
Curtis S. Florence et al.
MEDICAL CARE (2016)
RELAPSE IN OPIOID USE DISORDER: IMPLICATIONS FOR HEALTH CARE UTILIZATION AND COSTS
B. Brady et al.
VALUE IN HEALTH (2016)
NATURAL LANGUAGE PROCESSING-IDENTIFIED PROBLEM OPIOID USE AND ITS ASSOCIATED HEALTH CARE COSTS
E. T. Masters et al.
VALUE IN HEALTH (2016)
THE ASSOCIATION BETWEEN BUPRENORPHINE MEDICATION-ASSISTED TREATMENT ADHERENCE AND HEALTH CARE SERVICE UTILIZATION AND COSTS
J. Tkacz et al.
VALUE IN HEALTH (2016)
Meeting Abstracts - Annual Meeting 2016
Journal of Managed Care & Specialty Pharmacy (2016)
Meeting Abstracts - Academy of Managed Care Pharmacy Nexus 2016
Journal of Managed Care & Specialty Pharmacy (2016)
The Economic Burden of Opioid Abuse: Updated Findings
Noam Y. Kirson et al.
Journal of Managed Care & Specialty Pharmacy (2016)
The Association Between Stimulant, Opioid, and Multiple Drug Use on Behavioral Health Care Utilization in a Safety-Net Health System
Susan L. Calcaterra et al.
SUBSTANCE ABUSE (2015)
Budgetary impact of the utilization of buprenorphine/naloxone sublingual film and tablet for Medicaid in the United States
Carl V. Asche et al.
JOURNAL OF MEDICAL ECONOMICS (2015)
Characteristics of High-Cost Patients Diagnosed with Opioid Abuse
Amie Shei et al.
JOURNAL OF MANAGED CARE & SPECIALTY PHARMACY (2015)
Risk Factors for Relapse and Higher Costs Among Medicaid Members with Opioid Dependence or Abuse: Opioid Agonists, Comorbidities, and Treatment History
Robin E. Clark et al.
JOURNAL OF SUBSTANCE ABUSE TREATMENT (2015)
The global epidemiology and burden of opioid dependence: results from the global burden of disease 2010 study
Louisa Degenhardt et al.
ADDICTION (2014)
An overview of the patterns of prescription opioid use, costs and related harms in Australia
Bianca Blanch et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2014)
Factors predicting development of opioid use disorders among individuals who receive an initial opioid prescription: Mathematical modeling using a database of commercially-insured individuals
Bryan N. Cochran et al.
DRUG AND ALCOHOL DEPENDENCE (2014)
Prescription Opioid Abuse: A Literature Review of the Clinical and Economic Burden in the United States
Roxanne Meyer et al.
POPULATION HEALTH MANAGEMENT (2014)
The Economic Burden of Diagnosed Opioid Abuse Among Commercially Insured Individuals
J. Bradford Rice et al.
POSTGRADUATE MEDICINE (2014)
Analysis of Buprenorphine/Naloxone Dosing Impact on Treatment Duration, Resource Use and Costs in the Treatment of Opioid-Dependent Adults: A Retrospective Study of US Public and Private Health Care Claims
Amine Khemiri et al.
POSTGRADUATE MEDICINE (2014)
A Questionnaire to Assess the Relevance and Credibility of Observational Studies to Inform Health Care Decision Making: An ISPOR-AMCP-NPC Good Practice Task Force Report
Marc L. Berger et al.
VALUE IN HEALTH (2014)
Prevalence of Diagnosed Opioid Abuse and its Economic Burden in the Veterans Health Administration
Onur Baser et al.
PAIN PRACTICE (2014)
Cost Drivers of Prescription Opioid Abuse in Commercial and Medicare Populations
Margaret K. Pasquale et al.
PAIN PRACTICE (2014)
The Prevalence of Diagnosed Opioid Abuse in Commercial and Medicare Managed Care Populations
Robert Dufour et al.
PAIN PRACTICE (2014)
Persistence and healthcare utilization associated with the use of buprenorphine/naloxone film and tablet formulation therapy in adults with opioid dependence
Emilie Clay et al.
JOURNAL OF MEDICAL ECONOMICS (2014)
Medical cost savings associated with an extended-release opioid with abuse-deterrent technology in the US
Louis F. Rossiter et al.
JOURNAL OF MEDICAL ECONOMICS (2014)
Estimating the Costs of Opioid Abuse and Dependence from an Employer Perspective: a Retrospective Analysis Using Administrative Claims Data
J. Rice et al.
APPLIED HEALTH ECONOMICS AND HEALTH POLICY (2014)
Relationship Between Buprenorphine Adherence and Health Service Utilization and Costs Among Opioid Dependent Patients
Joseph Tkacz et al.
JOURNAL OF SUBSTANCE ABUSE TREATMENT (2014)
The Economic Burden of Opioid-Related Poisoning in the United States
Timothy J. Inocencio et al.
PAIN MEDICINE (2013)
Societal Costs of Prescription Opioid Abuse, Dependence, and Misuse in the United States
Howard G. Birnbaum et al.
PAIN MEDICINE (2011)
The PRISMA Statement for Reporting Systematic Reviews and Meta-Analyses of Studies That Evaluate Health Care Interventions: Explanation and Elaboration
Alessandro Liberati et al.
ANNALS OF INTERNAL MEDICINE (2009)
Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement
David Moher et al.
ANNALS OF INTERNAL MEDICINE (2009)
Economic Burden of Prescription Opioid Misuse and Abuse
Scott A. Strassels
JOURNAL OF MANAGED CARE PHARMACY (2009)
Do users of regularly prescribed opioids have higher rates of substance use problems than nonusers?
Mark J. Edlund et al.
PAIN MEDICINE (2007)
A checklist for retrospective database studies - Report of the ISPOR task force on retrospective databases
B Motheral et al.
VALUE IN HEALTH (2003)
Share Paper
